Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Clinical trial NCT02487979 · COMPLETED
Trial details
- NCT number
- NCT02487979
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-16
- Primary completion
- 2017-06-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.